MFG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
MFG Wealth Management's BMY Position: Q2 2026 in Review
MFG Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.64% in Q2 2026, selling an estimated $7.24K and leaving 19,446 shares worth $1.12M. The position accounts for 0.8% of the portfolio, ranked #59.
MFG Wealth Management first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.72M in Q4 2024. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- MFG Wealth Management held 19,446 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
- MFG Wealth Management sold 126 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.24K.
- Bristol-Myers Squibb made up 0.8% of MFG Wealth Management's portfolio in Q2 2026, its #59 holding.
- MFG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
- MFG Wealth Management's Bristol-Myers Squibb position peaked at $1.72M in Q4 2024.
- 565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on MFG Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.